Willard S T, Carroll J A, Randel R D, Harms P G, Welsh T H
Department of Animal Science, Texas Agricultural Experiment Station, Texas A&M University System, Overton 75684, USA.
Domest Anim Endocrinol. 1995 Jul;12(3):283-92. doi: 10.1016/0739-7240(95)00025-a.
The actions of corticotropin-releasing hormone (CRH), vasopressin (VP), the synthetic glucocorticoid dexamethasone (DEX), and mifepristone (RU 486), a glucocorticoid antagonist, on the secretion of adrenocorticotropin (ACTH) by cultured fallow deer corticotrophs were studied in vitro. On Day 5 of primary culture, corticotrophs were challenged for up to 4 hr with medium alone (Control), CRH, VP, DEX, forskolin (FSK), phorbol ester (TPA), cyclic AMP (cAMP), and/or RU 486 at various concentrations and combinations. CRH, VP, FSK and TPA each stimulated (P < 0.01) the secretion of ACTH in dose- and time-related manners. Relative to Control, CRH at 0.001 and 0.1 microM and VP at 0.01 and 1 microM increased (P < 0.01) medium concentration of ACTH by 7.3-, 13.5-, 3.7- and 9.0-fold, respectively. There was a treatment x incubation time interaction (P < 0.01) such that at 30-min posttreatment, CRH-induced ACTH secretion tended (P < 0.10) to be less than that obtained via VP treatment, whereas at 1, 3, and 4 hr posttreatment, medium concentration of ACTH from cells treated with 0.1 microM CRH was greater (P < 0.05) than that in cells treated with 1 microM VP. At equimolar doses of 0.01 and 0.1 microM, CRH was 3.4- and 3.0-fold more potent (treatment x dose, P < 0.05) than VP. Cotreatment with 1 microM DEX reduced (P < 0.001) the stimulatory effects of CRH (0.1 microM), VP (1 microM), FSK (10 microMs), TPA (0.1 microM), and cAMP (0.001 M). However, the coaddition of RU 486 (1 microM) to the CRH plus DEX- and the FSK plus DEX-treated wells partially negated the inhibitory effects of DEX. RU 486 completely negated the inhibitory effects of DEX on the VP-, TPA-, and cAMP-stimulated secretion of ACTH. These data indicate that CRH is a more potent stimulator of ACTH secretion than is VP in primary culture of fallow deer pituitary cells. This study also demonstrates the utility of an in vitro culture system to investigate stress-related hormonal interactions in cervids.
在体外研究了促肾上腺皮质激素释放激素(CRH)、血管加压素(VP)、合成糖皮质激素地塞米松(DEX)和糖皮质激素拮抗剂米非司酮(RU 486)对培养的黇鹿促肾上腺皮质激素细胞分泌促肾上腺皮质激素(ACTH)的作用。在原代培养的第5天,用单独的培养基(对照)、CRH、VP、DEX、福斯可林(FSK)、佛波酯(TPA)、环磷酸腺苷(cAMP)和/或不同浓度及组合的RU 486对促肾上腺皮质激素细胞进行长达4小时的刺激。CRH、VP、FSK和TPA均以剂量和时间相关的方式刺激(P<0.01)ACTH的分泌。相对于对照,0.001和0.1微摩尔/升的CRH以及0.01和1微摩尔/升的VP分别使培养基中ACTH的浓度增加(P<0.01)7.3倍、13.5倍、3.7倍和9.0倍。存在处理×孵育时间的相互作用(P<0.01),使得在处理后30分钟,CRH诱导的ACTH分泌倾向于(P<0.10)低于VP处理所获得的分泌,而在处理后1、3和4小时,用0.1微摩尔/升CRH处理的细胞培养基中ACTH的浓度高于(P<0.05)用1微摩尔/升VP处理的细胞。在0.01和0.1微摩尔/升的等摩尔剂量下,CRH的效力比VP高3.4倍和3.0倍(处理×剂量,P<0.05)。与1微摩尔/升DEX共同处理降低了(P<0.001)CRH(0.1微摩尔/升)、VP(1微摩尔/升)、FSK(10微摩尔/升)、TPA(0.1微摩尔/升)和cAMP(0.001摩尔/升)的刺激作用。然而,在CRH加DEX以及FSK加DEX处理的孔中共同添加RU 486(1微摩尔/升)部分抵消了DEX的抑制作用。RU 486完全抵消了DEX对VP、TPA和cAMP刺激的ACTH分泌的抑制作用。这些数据表明,在黇鹿垂体细胞的原代培养中,CRH是比VP更有效的ACTH分泌刺激剂。本研究还证明了体外培养系统在研究鹿类动物应激相关激素相互作用方面有用。